Nicholas Muzyczka

Corporate Officer/Principal en National Institutes of Health .

Health Technology

Consumer Services

Government

Cargos activos de Nicholas Muzyczka

Empresas	Cargo	Inicio	Fin
National Institutes of Health National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD.	Corporate Officer/Principal	07/03/2011	-

Historial de carrera de Nicholas Muzyczka

Antiguos cargos conocidos de Nicholas Muzyczka.

Empresas	Cargo	Inicio	Fin
Lacerta Therapeutics, Inc. Lacerta Therapeutics, Inc. BiotechnologyHealth Technology Lacerta Therapeutics, Inc. operates as a a clinical stage gene therapy company. The firm engages in development, production, and application of AAV vectors. The company was founded by Nicholas Muzyczka, Barry Byrne, Arun Srivastava, Coy Heldermon, Sergei Zolothukin, Kenneth Warrington, Ronald Mandel, Toadd E. Golde and Edgardo Rodriguez in 2017 and is headquartered in Alachua, FL.	Presidente	-	-
	Fundador	-	-
University of Florida	Corporate Officer/Principal	-	-
American Society of Gene Therapy	Director/Miembro de la Junta	07/03/2011	-
APPLIED GENETIC TECHNOLOGIES CORPORATION	Director/Miembro de la Junta	19/01/1999	-
APPLIED GENETIC TECHNOLOGIES CORPORATION	Fundador	19/01/1999	-

Formación de Nicholas Muzyczka.

The Johns Hopkins University

Doctorate Degree

Estadísticas

Internacional

Estados Unidos

Operativa

Director/Board Member	2
Founder	2
Corporate Officer/Principal	2

Sectorial

Health Technology	3
Consumer Services	3
Government	2

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas relacionadas

Empresas privadas	4
Beacon Therapeutics (USA), Inc. Beacon Therapeutics (USA), Inc. Pharmaceuticals: GenericHealth Technology Applied Genetic Technologies Corp. is a clinical stage biotechnology company, which engages in the usage of a gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. The firm also focuses on conducting clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL.	Health Technology
American Society of Gene Therapy
National Institutes of Health National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD.	Government
Lacerta Therapeutics, Inc. Lacerta Therapeutics, Inc. BiotechnologyHealth Technology Lacerta Therapeutics, Inc. operates as a a clinical stage gene therapy company. The firm engages in development, production, and application of AAV vectors. The company was founded by Nicholas Muzyczka, Barry Byrne, Arun Srivastava, Coy Heldermon, Sergei Zolothukin, Kenneth Warrington, Ronald Mandel, Toadd E. Golde and Edgardo Rodriguez in 2017 and is headquartered in Alachua, FL.	Health Technology

Ver las conexiones de la empresa